Related by context. All words. (Click for frequent words.) 73 AtuRNAi 71 siRNA therapeutic 71 DiLA2 70 RNAi therapeutics 70 siRNA therapeutics 69 exon skipping 69 RONDEL ™ 68 Fleximer 68 short interfering RNA 67 RNAi therapeutic 67 LNPs 67 DiLA 2 66 RONDEL TM 66 MediVas 66 RNAi compounds 66 Locked Nucleic Acid LNA 66 antagomirs 66 Novosom 66 proprietary PEGylation 66 MDRNA proprietary 66 stable nucleic acid 66 DsiRNA 65 antisense 65 sd rxRNA 65 cyclodextrin containing polymers 65 Alfacell proprietary ribonuclease 65 PEGylation 65 liposomal delivery 65 tkRNAi 65 antisense oligonucleotides 65 siRNA compounds 65 novel peptide 65 Cyclosert 65 RNAi 65 lipid nanoparticle 65 Locked Nucleic Acid 65 AtuPLEX 65 RNA interference RNAi 64 siRNA molecules 64 SMaRT ™ 64 anionic backbone 64 rxRNA 64 LentiVector 64 therapeutic monoclonal antibody 64 oligonucleotide therapeutics 63 siRNA 63 SMARTICLES ® 63 UsiRNAs 63 metalloenzymes 63 Electroporation 63 lipid nanoparticles 63 EyeGate ® II 63 targeted radiotherapeutic 63 liposomal formulation 63 rxRNA compounds 63 biologic therapeutics 63 Cyclosert TM 63 Nanobody 63 GelVac TM 63 DepoVax TM 63 lentiviral vector 63 liposomal 62 SNALP 62 ANTISENILIN ® 62 delivered RNAi therapeutic 62 Angiocept 62 Restoraderm 62 LNP formulations 62 advanced polymer conjugate 62 Stapled Peptide 62 Liposomal 62 Curaxins 62 siRNA sequences 62 HCV protease 62 immune modulation 62 DiLA2 Platform 62 siRNAs 62 Litx 62 patented NanoStat TM 62 Nanobody ® 62 Anticalins R 62 ALN TTR# 62 systemic siRNA 62 molecularly targeted 62 therapeutic monoclonal antibodies 62 antisense drug 62 siRNA binds 62 Curaxin 62 immunotherapeutics 62 Oligonucleotide 62 Dicer Substrate Technology 62 recombinant vaccines 62 Anticalin 62 systemic RNAi 62 Calando proprietary 62 KineMed 62 ZFP TF 62 IAP inhibitors 61 AAV vectors 61 ALN PCS 61 DiLA2 delivery 61 platinum chemotherapeutic 61 orally bioavailable 61 Sphingomab 61 vascular disrupting agents 61 Metallophile ™ Technology 61 immunotherapeutic 61 Chemetics R 61 Zysolin TM 61 humanized monoclonal antibodies 61 PEGylation technology 61 humanized antibodies 61 antisense drugs 61 Viprovex TM 61 microdroplet based 61 CBLC# 61 vivo electroporation 61 Fleximer R 61 proprietary Dicer Substrate Technology 61 BioSilicon 61 VeraTag 61 gene silencing 61 protein therapeutics 61 antibody fragment 61 selective kinase inhibitors 61 lipid nanoparticle LNP 61 novel RNAi therapeutics 61 PORxin TM 61 AAG geldanamycin analog 61 TIMERx R 61 anticancer agents 61 HyACT 61 pharmacological chaperone 61 histone deacetylase inhibitors 61 rxRNA ™ compounds 61 RNAi molecules 61 DuraSite 61 oral transdermal 61 Anticalins ® 61 anti CD3 61 Adnectin 61 engineered RAP peptides 61 PEGylated 61 KL4 Surfactant 61 proprietary transdermal 61 buccal delivery 61 NEUGENE R 60 Isis antisense 60 SNALP technology 60 therapeutic antibodies 60 Resten NG 60 taxane derivative 60 HSP# inhibitor 60 ddRNAi 60 Inc. Nasdaq ALNY 60 PARI Pharma GmbH 60 Bioral 60 XmAb 60 CAMBRIDGE Mass. Alnylam Pharmaceuticals 60 polymerase inhibitors 60 mediate RNAi 60 mda 7 60 EndoTAG TM 60 DermaPrep 60 chemically modified siRNA 60 lipidoid 60 optimized siRNA 60 acetylcholinesterase AChE 60 phage display 60 RNAi therapeutic targeting 60 immunomodulatory 60 ZFN technology 60 novel immunomodulatory 60 antisense oligonucleotide 60 investigational humanized monoclonal antibody 60 GMX# 60 transcutaneous immunization TCI 60 targeting CD# 60 humanized anti 60 multi kinase inhibitor 60 Onconase 60 HepDirect R 60 RNA antagonist 60 humanized antibody 60 ArQule Kinase Inhibitor Platform 60 dSLIM 60 RONDEL 60 JAK1 60 Affilin ® 60 kinase profiling 60 anticancer therapies 60 endosomal release 60 proprietary Biochronomer 60 therapeutics 60 transfection reagents 60 Guanilib 60 Factor VIIa 60 proteasome inhibitor 60 PARI Pharma 60 TriGrid ™ 60 Tekmira lipid nanoparticle 60 AKIP 60 Sangamo ZFP technology 60 sd rxRNA compounds 60 intranasal delivery 60 lipid particles 60 stem cell therapeutics 60 Homspera TM 60 COX Inhibiting Nitric Oxide 60 cancer therapeutics 60 LEAPS TM 60 recombinant antibodies 59 CRAC channel 59 novel immunotherapeutic 59 LentiVector technology 59 small molecule PEGylation 59 BiTE 59 molecular chaperone 59 iPSC 59 NeoLipid R 59 virus AAV 59 targeted antifolate 59 small molecule inhibitors 59 morpholino 59 Aurora Kinase 59 RNAi gene silencing 59 Ii Key 59 Atu# 59 proprietary biomaterials 59 bevacizumab Avastin ® 59 peptide conjugated 59 investigational antibody 59 nanomedicines 59 Biochronomer 59 RNA interference 59 adenovector 59 proteasome inhibitors 59 recombinant protein 59 Myolimus 59 RNA Interference RNAi 59 Panzem 59 Cylene 59 DOS# 59 GelSite R polymer 59 iPSC technology 59 G Protein Coupled 59 RNA interference RNAi therapeutics 59 MVA BN R 59 anti infective treatments 59 Omacetaxine 59 Intravesical 59 LEX System 59 PKC# 59 AAV vector 59 Azedra 59 PROfusion 59 Hsp# inhibition 59 RNA antagonists 59 tranilast 59 ESBA# 59 small molecule activators 59 hormone LHRH antagonist 59 CA4P 59 Celator 59 MTP inhibitor 59 Quark Biotech Inc. 59 RNA silencing 59 CCX# 59 HTS assay 59 fatty acid amide hydrolase 59 Xencor XmAb 59 OMP #M# 59 Sym# 59 massively parallel sequencing 59 synthetic siRNAs 59 Bavarian Nordic patented 59 small molecule 59 peptide therapeutics 59 immune stimulatory 59 FGFR 59 patented NanoStat ™ 59 biochemical profiling 59 JAK inhibitors 59 humanized monoclonal 59 #ME# 59 CGEN # 59 Protein Kinase C 59 small interfering RNA 59 GelVac ™ 59 nucleic acid lipid 59 HDL Therapy 59 Tekmira SNALP technology 59 PORxin 59 Nanobodies 59 HepDirect 59 chimeric monoclonal antibody 59 isoform selective 59 TriGrid 59 selective inhibition 59 virosome 59 microRNA therapeutics 59 IgG1 antibody 59 A3 adenosine receptor 59 neuroprotectant 59 PI3K inhibitors 59 generation antisense 59 Squalamine 59 MEK inhibitors 59 proven DuraSite ® 59 Antisense 59 immune modulatory 59 renin inhibitor 59 targeting PCSK9 59 CYT# potent vascular disrupting 58 oncolytic 58 molecular chaperone regulation 58 Receptos 58 TLR Therapeutics 58 LNA TM 58 Aliskiren 58 Chemophase 58 eFlow Technology 58 Systemic Delivery 58 optical biosensors 58 Nektar PEGylation technology 58 pan HDAC inhibitor 58 Receptors GPCRs 58 Nanobodies ® 58 developing TB4 58 OXIGON 58 boron chemistry 58 tiapamil 58 proprietary polysaccharide 58 antibody humanization 58 chemotherapeutics 58 delipidation 58 TG# [003] 58 MKC# MKC# PP 58 Anavex #-# 58 anti secretory 58 ALN TTR 58 small molecule agonists 58 Tr DNA 58 vinca alkaloid 58 Symadex 58 Captisol ® 58 Pervasis 58 NTDDS 58 preclinically 58 Factor Receptor 58 biologic therapies 58 VEGF receptor 58 JAK#/JAK# 58 XmAb ™ 58 selective orally bioavailable 58 HuCAL 58 PI3K inhibitor 58 Aptamers 58 oncology therapeutics 58 nasal powder 58 CellPort Technologies 58 Ambrx 58 small molecule defensin 58 anticancer therapeutics 58 DURECT proprietary 58 IAP inhibitor 58 specific lectin receptors 58 Xanafide 58 zinc finger nuclease 58 proprietary LNA 58 immunotherapeutic vaccine 58 BHT DNA 58 HCV protease inhibitors 58 molecular biomarkers 58 tkRNAi technology 58 Anticalin ® 58 2DG 58 Scancell 58 histone deacetylase HDAC 58 immunotoxins 58 CXCR4 receptor 58 DiLA2 platform 58 MEK inhibitor 58 kinase assay 58 SMARTICLES 58 Aptamer 58 lipid particles SNALP 58 Eligen ® Technology 58 pegylation 58 covering SNALP 58 cancer immunotherapies 58 Tarvacin TM 58 HCV protease inhibitor 58 antibody therapeutics 58 oxidative stress inducer 58 biotherapeutics 58 Preclinical studies suggest 58 drug zotarolimus 58 AvalonRx R 58 vivo imaging 58 PNP inhibitor 58 Panzem R 58 M2 subunit 58 epothilones 58 amikacin 58 bioadhesive polymer core 58 AKT inhibitor 58 Pentraxin 2 58 AEG# 58 Transfluor 58 monoclonal antibody 58 cationic lipid 58 ENMD # 58 Tekmira SNALP 58 proprietary dermal 58 Morpholino 58 engineered proteases 58 Janus kinase 58 intracellular uptake 58 Onalta 58 selective kinase inhibitor 58 Anticalin R 58 NanoStat 58 product platforms AZX# 58 Transdel TM 58 anti amnesic 58 siRNA molecule 58 Radiation Therapy SIRT 58 delta isoform 58 Nanobodies R 58 RECOTHROM R 58 POTELLIGENT ® 58 ESPRIT therapy 58 short hairpin RNAs 58 MP4 molecule 58 p# inhibitor 58 intracellular signaling pathways 58 PathHunter 58 vascular disrupting 58 CompoZr 58 AVI NEUGENE 58 neuroprotective properties 58 polymer conjugate technology 58 thapsigargin 58 Personalized Immunotherapy 58 AQUA ® 57 Ibis T# 57 PNT# 57 oncolytic virus 57 c Raf kinase 57 metabolomics 57 HepDirect prodrug 57 KL4 surfactant 57 Anticalins 57 therapeutic antibody 57 poly ADP ribose polymerase 57 siRNA reagents 57 accumulate preferentially 57 Fc fusion protein 57 utilizes InSite Vision 57 NovaDel oral spray 57 siRNA conjugates 57 lentiviral vectors 57 motexafin gadolinium Injection 57 novel peptides 57 SGLT Inhibitors 57 THR beta agonist 57 Micromet BiTE 57 ActivX 57 Viprovex R 57 resorbable biomaterials 57 HSP# inhibitors 57 CEQ# 57 patented Bioral 57 MT# MEDI 57 DNAi 57 EZN 57 Investigational eFlow Nebulizer System 57 intravesical instillation 57 RXi proprietary 57 polyclonal antibody 57 RNA Interference 57 PDE4 inhibitor 57 immunotherapy 57 siRNA constructs 57 aptamer therapeutics 57 nanoviricide 57 aerosolized KL4 surfactant 57 LHRH antagonists 57 prodrugs 57 GelSite polymer 57 anticancer agent 57 Enkephalin 57 PEGylated Fab fragment 57 IMA# 57 Scil Proteins 57 aTyr Pharma 57 oral antiviral 57 investigational HCV polymerase 57 nanoviricides 57 Restoraderm R technology 57 antibody therapies 57 uricase 57 Captisol 57 cancer immunotherapy 57 antisense compounds 57 XmAb ® 57 IMiDs R 57 cartilage regeneration 57 ProLindac TM 57 NEUGENE 57 anti angiogenic drugs 57 vascular disrupting agent 57 ATL# [002] 57 CobaCyte 57 antitumor 57 Nektar pulmonary 57 transdermal delivery 57 Adenosine Therapeutics 57 Fibroblast Growth Factor Receptor 57 Mucosal 57 functional genomics 57 Chrysalin 57 pRNA 57 dAbs 57 Doxorubicin 57 siRNA mediated 57 BioLeap 57 PARP inhibitors 57 kidney urologic 57 interfering RNAs 57 REG1 57 antimitotic 57 Flt3 57 Etubics 57 zinc finger nucleases 57 Enhanze TM Technology 57 RenaZorb TM 57 GelVac 57 histone deacetylase HDAC inhibitors 57 tyrosine kinase inhibitor 57 indibulin 57 RECALL VAX TM 57 oncolytic viruses 57 vaccine adjuvant 57 vinca alkaloids 57 PRT# 57 AMPK activators 57 CCR9 antagonist 57 metaglidasen 57 synthetic peptide 57 Eric von Hofe 57 covalent drugs 57 Quanterix 57 TOCOSOL 57 RNA therapeutics 57 Enhanze Technology 57 angiogenesis inhibitor 57 photodynamic 57 proprietary hydrogel 57 cMET 57 Bevasiranib 57 developing topically administered 57 OX1 57 proprietary Locked Nucleic 57 RNAi Therapeutics 57 ribonuclease 57 biomarker identification 57 Immunotherapy 57 microdroplet 57 antifolate 57 aptamers 57 ProNAi 57 Cdc7 57 NS4A 57 potent topoisomerase II 57 BioSilicon TM 57 XmAb# 57 TLR9 agonist 57 antibody fragments 57 ChiSys 57 biomarker discovery 57 fibrin derived 57 Aganocide 57 Cobalamin 57 DermaVir 57 ACTCellerate 57 vivo validation 57 histone deacetylase inhibitor 57 Affibody 57 Hedgehog signaling pathway 57 treat refractory angina 57 Viamet 57 AMPAKINE 57 molecule sequencing 57 introduced NEUGENE 57 Lpathomab 57 antitumoral 57 molecular virology 57 somatostatin analogue 57 nanoparticle formulation 57 Hydroxyapatite HAp 57 ATL# [001] 57 ZFN modified 57 Ii protein 57 topically delivered 57 Tekmira SNALP stable 57 Lacromin 57 siRNA duplexes 57 DPX Survivac 57 Small Molecule 57 ZFNs 57 poly ethylene glycol PEG 57 geldanamycin 57 neuroprotection 57 preclinical efficacy 57 Taxanes 56 metabolomics driven 56 fibrotic disease 56 SIMPLE Antibody TM 56 anti CD# antibodies 56 novel antibody therapeutics 56 deacetylase inhibitors 56 novel anticancer 56 Fibrin MB 56 potent inhibitors 56 peripherally acting 56 Stapled Peptides 56 Bioral ® 56 CollaRx 56 Chimigen 56 siRNAs targeting 56 Alexza Staccato 56 prostone 56 DepoFoam 56 electroporation 56 Bezielle 56 Vascugel 56 Hydrogel Nanoparticle Aggregate 56 bioartificial liver 56 monoclonal antibody mAb 56 carbon nanomaterials 56 OncoVEX 56 monoclonal antibodies 56 DepoVax 56 human parthenogenetic stem 56 Affymetrix GeneChip ® 56 miRNA therapeutics 56 enhance ApoA 56 systemic RNAi therapeutic 56 MALDI-TOF/TOF 56 Vascular Endothelial Growth 56 SGLT2 inhibitors 56 vivo fluorescence imaging 56 VitiGam 56 biased ligand 56 alpha folate receptor 56 Genisphere 56 anti angiogenic 56 CTLA4 Ig 56 mitotic kinesin 56 protein tyrosine phosphatase 1B 56 ZFP technology 56 molecular imaging radiopharmaceutical 56 ZFN 56 HCV replication 56 rAAV 56 Aganocide ® 56 potently inhibit 56 gamma secretase inhibitors 56 intracellular protein 56 Curaxin CBLC# 56 recombinant adeno associated 56 therapeutic proteins 56 Biolimus A9 56 Contramid 56 oral prodrug 56 Acetylon 56 radiation sensitizer 56 Cand5 56 vaccines oncolytic virus 56 Exherin TM 56 synthetic retinoid 56 NovaBay Aganocide compounds 56 defensin mimetic antibiotic 56 biocatalysts 56 mRNA antagonists 56 transrenal DNA 56 UsiRNA 56 mucosal vaccines 56 Semafore 56 peptide antigens 56 MEK ERK 56 anticancer drugs 56 peptide synthesis 56 SR Pharma 56 HDAC inhibition 56 ViaDerm 56 multidose dry 56 thymosin beta 4 56 BioSET 56 recombinant antibody 56 novel topoisomerase 56 sulfonylhydrazine class 56 Photodynamic therapy PDT 56 cleavable linker 56 NeuroTrans TM 56 Eg5 56 punctal plug drug 56 intranasal vaccines derived 56 carbohydrate compounds 56 NP2 56 adult mesenchymal stem 56 Emisphere eligen R 56 JAK inhibitor 56 oral Janus kinase 56 Regado Biosciences 56 DNA plasmids 56 Galenea 56 Sudhir Agrawal D.Phil 56 chemotherapeutic agent 56 TAFA# 56 Bioral R 56 OXIGON TM 56 familial amyloidotic polyneuropathy FAP 56 haplotyping 56 proprietary electroporation 56 viral vectors 56 Crucell PER.C6 ® 56 advanced pulmonary liposome 56 therapeutic modality 56 antiviral therapies 56 theranostic 56 NeoLipid TM 56 non nucleoside 56 Peptidomics 56 adenoviral 56 synthetic peptides 56 Pfenex Expression Technology 56 Pertuzumab 56 nucleic acid 56 CORT # 56 Inovio DNA 56 Iluvien ® 56 anticoagulant reversing agent 56 HGS ETR1 mapatumumab 56 proprietary Lipid Vector 56 BACcel 56 BST Gel 56 Interferon alpha 56 Aganocide R 56 NuMimetic TM 56 paclitaxel Taxol 56 Phylomer 56 GeneICE 56 RNAi Therapeutic 56 HTRF 56 NP2 Enkephalin 56 microtubule inhibitor 56 derived neurotrophic factor 56 Archexin 56 ADME Tox 56 lentiviral 56 quantitative proteomics 56 agonist compounds 56 BCR ABL inhibitors 56 Tß4 56 Unit Dose Budesonide 56 potentiator 56 amino acid peptide 56 acetonide FA 56 detection reagents 56 JAK3 56 nanoparticulate 56 Controlled Delivery 56 HIV protease inhibitor 56 selective antagonist 56 cationic lipids 56 molecular chaperone amplification 56 small molecule tyrosine 56 Gleevec resistant 56 Capsulution 56 AvalonRx ® 56 HuCAL antibody 56 triphendiol 56 chemotherapeutic drug 56 Invisicare R 56 antisense inhibitor 56 Aurora kinase 56 beta Estradiol 56 Enhanze 56 NanoCrystal technology 56 Liprotamase 56 Bioral Amphotericin B. 56 ALN VSP 56 PSMA ADC 56 Hsp# inhibitors 56 oral taxane 56 factor G CSF 56 using ImmunoGen TAP 56 adrenal steroid hormones 56 DispersinB R 56 PET tracers 56 FK# 56 NS4B 56 Genedata Expressionist ® 56 OXi# 56 metabolite identification 56 NPC 1C 56 fusion proteins 56 Lixivaptan 56 PRLX # 56 NexACT 56 TLR8 56 AQD class 56 CD4 monoclonal antibody 56 protein receptors lectins 56 tyrosine kinase inhibitor TKI 56 immunotherapies 56 including Cobalamin TM 56 DETERx ™ 56 humanised monoclonal antibody 56 Tumour Vascular Disrupting Agent 55 Amphotericin B 55 NeuroSTAT ® 55 Selective Electrochemical Tumor Ablation 55 pathophysiological effects 55 sodium glucose cotransporter 55 Tarmogen 55 monoclonal antibody MAb 55 Cobalamin TM mediated 55 GPCR 55 electro optic polymer 55 DepoVax ™ 55 immunoregulation 55 vivo RNAi 55 predictive toxicology 55 histone methyltransferases HMTs 55 BRAF inhibitor 55 bioconjugation 55 biocatalysis 55 Skinvisible patented polymer 55 CB2 selective 55 antisense inhibitors 55 GLPG# 55 doxorubicin Transdrug R 55 antigen sparing 55 Dicerna 55 KinomeScan 55 selectively inhibit 55 SERCA2a 55 Transfection Reagent 55 tyrosine kinase inhibitors 55 encapsulates siRNAs 55 SELDI 55 PROT biotechnology 55 BGC# 55 solubilization 55 nitric oxide donating 55 novel orally administered 55 reversible inhibitor 55 platform HDL Mimetic 55 NEUGENE antisense 55 ZFP Therapeutics 55 Intravail ® 55 generation NEUGENE antisense 55 antiangiogenesis therapies 55 small molecule glucokinase 55 GPCRs 55 RainStorm TM 55 nanoparticle aggregates 55 xenograft models 55 nanocarriers 55 Monoclonal Antibody 55 nanolithography 55 XmAb TM 55 Symphogen 55 Homspera 55 Hemopurifier TM 55 histone deacetylase HDAC inhibitor 55 5 HT4 receptor 55 rusalatide acetate 55 Microcyn Technology platform 55 photodynamic therapy PDT 55 Avila Therapeutics 55 doxorubicin HCl 55 compound PMX # 55 DNA intercalator 55 IMiDs ® 55 entinostat 55 OncoVEX GM CSF 55 PluriCells 55 AFFITOME 55 selective adenosine 55 Gefitinib 55 LTQ Orbitrap 55 druggable targets 55 Sphingomab TM 55 ARRY # 55 personalized immunotherapy 55 Bavituximab 55 Elesclomol 55 trans splicing 55 Western Blotting 55 depsipeptide 55 nanopharmaceutical 55 thymidylate synthase TS 55 clinically validated targets 55 therapeutic radiopharmaceuticals 55 RAV# 55 HuCAL PLATINUM 55 Nautilus Biotech 55 chemotherapeutic agents 55 synthetic siRNA 55 polyclonal antibodies 55 direct thrombin inhibitors 55 Tumor Necrosis Factor 55 Carfilzomib 55 multitargeted 55 CARBOSOME TM formation 55 Blinatumomab 55 NS#/#A protease 55 SynCon TM 55 therapeutic peptide 55 nutlin 55 proprietary liposomal 55 Micell 55 TPI ASM8 55 protein kinase inhibitor 55 PolyActive 55 bioactive lipids 55 nanopore sequencing 55 MicroDose 55 ISF# 55 alkylating 55 PI3K/mTOR 55 Cetrorelix 55 rHuPH# recombinant human 55 Tomophase 55 protein mTOR 55 transmucosal delivery 55 antisense therapeutics 55 HGS# 55 NS5A 55 Avian Transgenic Technology 55 OTCBB PWRM.OB 55 #beta HSD1 55 allosteric modulation 55 proprietary Customized Linker 55 P#X# antagonist 55 LPA1 55 mertansine 55 tests miRview TM 55 vitro assay 55 hyaluronidase rHuPH# 55 nanoemulsion 55 cheminformatics 55 biocatalytic 55 transfection reagent 55 anti angiogenic agent 55 biotherapeutic 55 Electronic Brachytherapy 55 ophthalmic therapeutics 55 Elvitegravir 55 Gamma secretase 55 derivatives Radilex TM 55 Talabostat 55 skeletal sarcomere activators 55 regenerative therapeutics 55 topical dermatological products 55 hypoxia inducible factor 55 carbohydrate polymer 55 selective androgen receptor modulators 55 Optical Biopsy System 55 PLK1 SNALP 55 MT#/MEDI-# 55 Stem Cell Innovations 55 docetaxel Taxotere ® 55 Novolimus 55 targeted covalent 55 tumor vascular disrupting 55 antibiofilm 55 OMP #R# 55 disease modifying 55 Cathepsin S 55 Payload TAP technology 55 immatics 55 phage display technology 55 oligonucleotides 55 Daclizumab 55 XL# XL# 55 Vaxart 55 genomic proteomic 55 VDAs 55 VisEn Medical 55 Genedata Expressionist 55 Pentad TM 55 oligonucleotide 55 MolecularBreeding